ASPM is aberrantly expressed in various tumors, such as glioblastoma (41), endometrial adenocarcinoma (42), pancreatic cancer (43), prostate adenocarcinoma (44), and ovarian cancer (45, 46), and is associated with tumor prognosis. Here, ASPM is linked to neoplasm.